Q & A: Antibiotic Resistance and the OVERCOME Trial | NIH: National Institute of Allergy and Infectious Diseases

Q & A: Antibiotic Resistance and the OVERCOME Trial | NIH: National Institute of Allergy and Infectious Diseases

Monday, May 6, 2019

Q&A: Antibiotic Resistance and the OVERCOME Trial

As bacteria gain resistance to common antibiotics, infections are becoming more difficult to treat. A new Q&A on the NIAID Now blog features Dr. Keith Kaye, principal investigator in the OVERCOME trial, which seeks to understand the best ways to extend the lifespans of antibiotics as useful treatment options. NIAID Now spoke with Dr. Kaye about his work in this field, and about his goals for future studies.